Transcriptional regulation of IL-2 in health and autoimmunity

Autoimmunity Reviews

Volumn 8, Issue 3, 2009, Pages 190-195

  Crispín, José C ^a   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chromatin remodeling; FoxP3; IL 2; Systemic lupus erythematosus; Transcriptional regulation

Indexed keywords

CD28 ANTIGEN; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOKINE PRODUCTION; GENE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; INTERLEUKIN 2 GENE; NONHUMAN; PROMOTER REGION; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD28; AUTOIMMUNITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTORS; GENE REGULATORY NETWORKS; HUMANS; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 58149459511     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.042     Document Type: Review

References (40)

1. Ma A., Koka R., and Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24 (2006) 657-679
2. Crispin J.C., and Tsokos G.C. Novel molecular targets in the treatment of systemic lupus erythematosus. Autoimmun Rev 7 (2008) 256-261
3. Setoguchi R., Hori S., Takahashi T., and Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201 (2005) 723-735
4. Valencia X., Yarboro C., Illei G., and Lipsky P.E. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178 (2007) 2579-2588
5. Kim H.P., Imbert J., and Leonard W.J. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev 17 (2006) 349-366
6. Helms W.S., Jeffrey J.L., Holmes D.A., Townsend M.B., Clipstone N.A., and Su L. Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells. J Leukoc Biol 82 (2007) 361-369
7. Pfeuffer I., Klein-Hessling S., Heinfling A., Chuvpilo S., Escher C., Brabletz T., et al. Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. J Immunol 153 (1994) 5572-5585
8. Brunner C., Sindrilaru A., Girkontaite I., Fischer K.D., Sunderkotter C., and Wirth T. BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses. EMBO J 26 (2007) 3191-3202
9. Cismasiu V.B., Ghanta S., Duque J., Albu D.I., Chen H.M., Kasturi R., et al. BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes. Blood 108 (2006) 2695-2702
10. Murayama A., Sakura K., Nakama M., Yasuzawa-Tanaka K., Fujita E., Tateishi Y., et al. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J 25 (2006) 1081-1092
11. Adachi S., and Rothenberg E.V. Cell-type-specific epigenetic marking of the IL2 gene at a distal cis-regulatory region in competent, nontranscribing T-cells. Nucleic Acids Res 33 (2005) 3200-3210
12. Thomas R.M., Chunder N., Chen C., Umetsu S.E., Winandy S., and Wells A.D. Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes. J Immunol 179 (2007) 7305-7315
13. Bandyopadhyay S., Dure M., Paroder M., Soto-Nieves N., Puga I., and Macian F. Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells. Blood 109 (2007) 2878-2886
14. Shi L., Zhao G., Qiu D., Godfrey W.R., Vogel H., Rando T.A., et al. NF90 regulates cell cycle exit and terminal myogenic differentiation by direct binding to the 3′-untranslated region of MyoD and p21WAF1/CIP1 mRNAs. J Biol Chem 280 (2005) 18981-18989
15. Pei Y., Zhu P., Dang Y., Wu J., Yang X., Wan B., et al. Nuclear export of NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser647 in response to CD28 costimulation. J Immunol 180 (2008) 222-229
16. Shi L., Qiu D., Zhao G., Corthesy B., Lees-Miller S., Reeves W.H., et al. Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cells. Nucleic Acids Res 35 (2007) 2302-2310
17. Safford M., Collins S., Lutz M.A., Allen A., Huang C.T., Kowalski J., et al. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol 6 (2005) 472-480
18. Skerka C., Decker E.L., and Zipfel P.F. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J Biol Chem 270 (1995) 22500-22506
19. Collins S., Wolfraim L.A., Drake C.G., Horton M.R., and Powell J.D. Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcription. J Immunol 177 (2006) 8301-8305
20. Pan F., Ye Z., Cheng L., and Liu J.O. Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT). J Biol Chem 279 (2004) 14477-14480
21. Matsuoka H., Fujimura T., Hayashi M., Matsuda K., Ishii Y., Aramori I., et al. Disruption of HDAC4/N-CoR complex by histone deacetylase inhibitors leads to inhibition of IL-2 gene expression. Biochem Pharmacol 74 (2007) 465-476
22. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446 (2007) 685-689
23. Bruniquel D., and Schwartz R.H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4 (2003) 235-240
24. Shevach E.M. Regulatory T cells in autoimmmunity*. Annu Rev Immunol 18 (2000) 423-449
25. Mantel P.Y., Ouaked N., Ruckert B., Karagiannidis C., Welz R., Blaser K., et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 176 (2006) 3593-3602
26. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19 (2007) 345-354
27. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
28. Chen C., Rowell E.A., Thomas R.M., Hancock W.W., and Wells A.D. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J Biol Chem 281 (2006) 36828-36834
29. Li B., Samanta A., Song X., Iacono K.T., Bembas K., Tao R., et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci U S A 104 (2007) 4571-4576
30. Tao R., de Zoeten E.F., Ozkaynak E., Chen C., Wang L., Porrett P.M., et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13 (2007) 1299-1307
31. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
32. Nandiwada S.L., Li W., Zhang R., and Mueller D.L. p300/Cyclic AMP-responsive element binding-binding protein mediates transcriptional coactivation by the CD28 T cell costimulatory receptor. J Immunol 177 (2006) 401-413
33. Macian F., Garcia-Cozar F., Im S.H., Horton H.F., Byrne M.C., and Rao A. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109 (2002) 719-731
34. Thomas R.M., Gao L., and Wells A.D. Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J Immunol 174 (2005) 4639-4646
35. Hsueh Y.P., Liang H.E., Ng S.Y., and Lai M.Z. CD28-costimulation activates cyclic AMP-responsive element-binding protein in T lymphocytes. J Immunol 158 (1997) 85-93
36. Tenbrock K., Juang Y.T., Tolnay M., and Tsokos G.C. The cyclic adenosine 5′-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J Immunol 170 (2003) 2971-2976
37. Tenbrock K., Juang Y.T., Gourley M.F., Nambiar M.P., and Tsokos G.C. Antisense cyclic adenosine 5′-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J Immunol 169 (2002) 4147-4152
38. Juang Y.T., Wang Y., Solomou E.E., Li Y., Mawrin C., Tenbrock K., et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J Clin Invest 115 (2005) 996-1005
39. Katsiari C.G., Kyttaris V.C., Juang Y.T., and Tsokos G.C. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J Clin Invest 115 (2005) 3193-3204
40. Kyttaris V.C., Juang Y.T., Tenbrock K., Weinstein A., and Tsokos G.C. Cyclic adenosine 5′-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus. J Immunol 173 (2004) 3557-3563